Literature DB >> 2437982

Fetal hemoglobin levels and beta (s) globin haplotypes in an Indian populations with sickle cell disease.

A E Kulozik, B C Kar, R K Satapathy, B E Serjeant, G R Serjeant, D J Weatherall.   

Abstract

To further explore the cause for variation in hemoglobin F (Hb F) levels in sickle cell disease, the beta globin restriction-fragment length polymorphism haplotypes were determined in a total of 303 (126 SS, 141 AS, 17 S beta(0), 7 A beta, (0) and 12 AA) Indians from the state of Orissa. The beta(s) globin gene was found to be linked almost exclusively to a beta(S) haplotype ( -++-), which is also common in Saudi Arabian patients from the Eastern Province (referred to as the Asian beta(s) haplotype). By contrast, the majority of beta A and beta(0) thalassemia globin genes are linked to haplotypes common in all European and Asian populations (+-----[+/-]; --++-++). Family studies showed that there is a genetic factor elevating Hb F levels dominantly in homozygotes (SS). This factor appears to be related to the Asian beta(s) globin haplotype, and a mechanism for its action is discussed. There is also a high prevalence of an independent Swiss type hereditary persistence of fetal hemoglobin (HPFH) determinant active in both the sickle cell trait and in sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437982

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Beta-thalassaemia: molecular pathogenesis and clinical variability.

Authors:  A E Kulozik
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

2.  Haematology research in India: past, present and future.

Authors:  Kanjaksha Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2011-05-08       Impact factor: 0.900

3.  Intrinsic potential for high fetal hemoglobin production in a Druz family with beta-thalassemia is due to an unlinked genetic determinant.

Authors:  A Oppenheim; A Yaari; D Rund; E A Rachmilewitz; D Nathan; C Wong; H H Kazazian; B Miller
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

Review 4.  Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.

Authors:  Swee Lay Thein; Stephan Menzel; Mark Lathrop; Chad Garner
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

5.  The frequency and origin of the sickle cell mutation in the district of Coruche/Portugal.

Authors:  C Monteiro; J Rueff; A B Falcao; S Portugal; D J Weatherall; A E Kulozik
Journal:  Hum Genet       Date:  1989-06       Impact factor: 4.132

6.  Fetal Haemoglobin and β-globin Gene Cluster Haplotypes among Sickle Cell Patients in Chhattisgarh.

Authors:  Sanjana Bhagat; Pradeep Kumar Patra; Amar Singh Thakur
Journal:  J Clin Diagn Res       Date:  2013-02-01

Review 7.  Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.

Authors:  Stephan Menzel; Swee Lay Thein
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

8.  Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.

Authors:  Sneha Dadheech; Suman Jain; D Madhulatha; Vandana Sharma; James Joseph; A Jyothy; Anjana Munshi
Journal:  Mol Biol Rep       Date:  2014-02-02       Impact factor: 2.316

9.  The proximal element of the beta globin locus control region is not functionally required in vivo.

Authors:  A E Kulozik; S Bail; A Bellan-Koch; C R Bartram; E Kohne; E Kleihauer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

10.  Sickle cell disease in central India.

Authors:  Archana B Patel; Ambarish M Athavale
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.